Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines
暂无分享,去创建一个
Y. Barenholz | G. Storm | D. Crommelin | E. Phillips | J. Ljubimova | M. Dobrovolskaia | J. Szebeni | M. Castells | K. Turjeman